| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |